Hi there, i3 Consult is proud to announce the launch of new content for www.i3consult.com. As shown on our i3 Services page, this launch is to reflect our new service offer of greater niche consultancy solutions for “4Ps” sectors...
Hi there, We are pleased to announce i3 Consult is partnering with iClinical to support our services in clinical trial management. iClinical provides a customised mobile/cloud data platform to collect and analyse clinical trial data...
The competitiveness of drug development has been the impetus for new and accelerated regulatory pathways. While the growing patient-centric healthcare market coupled with a vested interest in safety information from a range of governmental and...
Biotechnology R and D spending reached $45.7 billion by FY2016, this represented a 12% increase from the previous financial year. This was the seventh consecutive year that biotech companies increased their cumulative R&D spending and...
As the healthcare industry moves to a more value-focused approach, hospital and healthcare organisations are being challenged to improve healthcare quality while also becoming more efficient in their service outcomes. Ehealth and its technological advances...
At i3 Consult we have been successful in ensuring that a biotechnology client of ours retained a significant portion of funds upon initiating their highly successful IPO. Our client was a university based incubator company...